Streetbeat News

Partnerships

ARGT

MELI

The Global X MSCI Argentina ETF (ARGT) has entered a bull market, surging over 20% after Javier Milei's presidential election win in Argentina. ARGT, with MercadoLibre Inc. (MELI) as its top holding, saw a $13 million inflow. Milei's Washington meetings with U.S. officials and international organizations are crucial for Argentina's economic path, focusing on hyperinflation and economic reforms.

Portfolio Pulse from Piero Cingari

November 27, 2023 | 10:16 pm

SCBFY

Standard Chartered Bank (China) has begun offering digital yuan exchange services, making it the first foreign bank to join China's CBDC pilot testing. The bank is collaborating with City Bank Clearing Services to provide access to the digital yuan's interconnection platform. China's digital yuan, or e-CNY, has seen significant adoption with $253.6 billion in transactions and 120 million wallets since 2020. The pilot is active in 26 cities and provinces, and the digital yuan is expected to enhance payment experiences and international financial market integration.

Portfolio Pulse from Khyathi Dalal

November 27, 2023 | 10:00 pm

AUDC

CGNT

EIS

IZRL

TEVA

Israel and Hamas have agreed to extend their truce by an additional two days. The extension follows a prisoner exchange and is supported by Qatar and Egypt. U.S. Secretary of State Antony Blinken acknowledged Qatar's mediation role. President Biden and UN Secretary-General Antonio Guterres expressed support for the extension to aid humanitarian efforts in Gaza. Elon Musk visited Israel and discussed the potential use of Starlink in Gaza, subject to Israeli approval. The iShares MSCI Israel ETF and ARK Israel Innovative Technology ETF saw gains, as did Israeli tech stocks AutoCodes, Cognyte Software, and Teva Pharmaceuticals.

Portfolio Pulse from Piero Cingari

November 27, 2023 | 9:35 pm

ANAB

CNTA

AnaptysBio, Inc. has secured an exclusive license for Centessa Pharmaceuticals' BDCA2 modulator antibody portfolio, including the lead asset CBS004 (to be renamed ANB101), for treating autoimmune and inflammatory diseases. Anaptys plans to file an IND for ANB101 in H2 2024 and expects to maintain a cash runway through 2026. The deal involves a $7M upfront payment from Anaptys to Centessa, with additional potential milestone payments and royalties on sales.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:16 pm

OLED

BOE Technology Group and Universal Display Corporation have entered into long-term agreements for OLED technology. These agreements will allow BOE to use Universal Display's proprietary UniversalPHOLED technology and materials for OLED displays. The collaboration is expected to enhance product offerings and leverage Universal Display's expertise in the OLED market.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:16 pm

BA

Millennium Space Systems, a subsidiary of Boeing (NYSE:BA), has completed the Critical Design Review (CDR) for the Missile Track Custody (MTC) space vehicle. This milestone was achieved less than a year after the project was authorized and only five months after the Preliminary Design Review. The company will now proceed to deliver six space vehicles for MTC Epoch 1, which includes two additional vehicles from the original contract and four more from an expanded Other Transaction Authority. The focus on digital engineering and a mature spacecraft architecture has allowed for rapid progress and is expected to reduce risks in vehicle production.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:02 pm

ESGL

ESGL Holdings has renewed a multi-year contract with Singapore Refining Company. The terms of the contract have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:02 pm

PCVX

STRO

Vaxcyte, Inc. has exercised an option and entered into a manufacturing rights agreement with Sutro Biopharma, Inc. to gain control over the development and manufacture of cell-free extract for its pneumococcal conjugate vaccine (PCV) franchise. This move is part of Vaxcyte's strategy to support the global commercialization of its PCV candidates, VAX-24 and VAX-31. Vaxcyte paid Sutro $50 million in cash and will pay an additional $25 million within six months, with potential future milestone payments totaling up to $60 million.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:01 pm

SVRE

SaverOne Inc (NASDAQ:SVRE) stock surged over 50% after announcing a pilot with System Logistics to equip a portion of their vehicles with SaverOne's safety solutions. The pilot could expand to the entire fleet, marking a significant step in SaverOne's growth in Europe and strengthening its presence in Italy.

Portfolio Pulse from Henry Khederian

November 27, 2023 | 8:46 pm

PLTR

Palantir Technologies, Inc (NYSE:PLTR) experienced a slight decline on Monday after a 10% retracement from its 52-week high of $21.85. The stock had surged about 30% since October 31, driven by increased interest in AI and a seven-year contract with the U.K.'s NHS. Palantir also reported a Q3 earnings beat on November 2. Despite the recent pullback, technical analysis suggests the stock may have found a local bottom and could rise if it regains the eight-day EMA. Resistance is at $19.95 and $21.09, with support at $17.84 and $16.29.

Portfolio Pulse from Melanie Schaffer

November 27, 2023 | 8:44 pm